Novartis U.S. pharmaceuticals head to be James Callahan of Ciba.
Executive Summary
NOVARTIS U.S. PHARMACEUTICALS HEAD WILL BE CALLAHAN, the current head of Ciba's U.S. pharmaceuticals division, Ciba-Geigy and Sandoz announced May 7. James Callahan will report to Novartis worldwide health care division and pharmaceuticals sector head Pierre Douaze in Basel, Switzerland. The companies, which plan to merge when regulatory authorities have given approval, appointed positions for the merged U.S. operations of Novartis.